JPRN-jRCTs061180062Active, not recruitingPhase 3
The efficacy of reduced form of coenzyme Q10 in the Treatment of dementia - The efficacy of reduced form of coenzyme Q10 in the Treatment of dementia
ABE SATOSHI0 sites100 target enrollmentStarted: March 18, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 50age old to <= 89age old (—)
- Sex
- All
Inclusion Criteria
- •1)Diagnosis is one of five types of dementia.
- •Alzheimer disease, Vascular dementia, Dementia of Lewy Body, frontotemporal dementia, Mild Cognitive Impairment: (MCI)
- •2)Clinical Dementia Rating (CDR) is 0.5,1 or 2 (mild-moderate dementia).
- •3)Mini-Mental State Examination (MMSE) score is between 15 and 28.
- •4)Treatment has been kept with four drugs, donepezil, galantamine, rivastigmine, memantine and some other drug.
- •5)Agreement with clinical trial is between 50 and 89 years old.
- •6)A declaration of consent shall be valid if drawn up as a document providing sufficient evidence.
Exclusion Criteria
- •1)Metabolic encephalopathy (hypothyroidism, Vitamin B12 deficiency)
- •2)Post head trauma
- •3)Delirium due to any drugs
- •4)Alcohol abuse
- •5)Depression under medication
- •6)Mental disorder treated by antipsychotic drugs
- •7)Schizophrenia, mania, severe heart failure, and severe liver injury.
- •8)Chronic renal failure with creatinine clearance less than 20 ml/min.
- •9)Treated with malignancy
- •10) Investigator decides inappropriate for enrollment
Investigators
Similar Trials
Recruiting
Not Applicable
The efficacy of reduced form of coenzyme Q10 in the Treatment of dementiaDemenitaJPRN-UMIN000019587Shimane University100
Completed
Not Applicable
Effect of the REduced form of COenzyme Q10 Supplementation on endothelial function in chronic heart failurechronic heart failureJPRN-UMIN000012604Yokohama City University Medical Center20
Recruiting
Phase 2
Evaluation of The Therapeutic Role of Coenzyme Q10 and Coconut Oil in Acute Aluminum Phosphide Poisoning Outcomes:A Randomized Controlled Clinical TrialInjury, Occupational Diseases, PoisoningPACTR202101703883803Rasha Elhussieny Elsharkawy84
Completed
Not Applicable
Evaluation of the effects of Coenzyme Q10 on the serum concentration of interleukin 6 and interleukin 33 in hemodialysis patientsEnd Stage Renal Disease (Hemodialysis).Chronic kidney disease, stage 5 Chronic uraemia End stage kidney disease: in allograft failure NOS on dialysis without dialysis or transplantIRCT2015061722637N2Vice chancellor for research, Kerman University of Medical Sciences130
Completed
Phase 2
Effect of supplementation in treatment of patients with polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeIRCT201612315623N97Vice chancellor of research, Bushehr University of Medical Sciences40